Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms

Nutritional Neuroscience

Volumn 7, Issue 4, 2004, Pages 247-249

  Stokes, Caroline ^a   Peet, Malcolm ^a  

^a Rotherham Mental Health Services   (United Kingdom)

Author keywords

Clozapine; Polyunsaturated fatty acids; Schizophrenia; Sugar

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; POLYUNSATURATED FATTY ACID; SUGAR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG USE; FAT INTAKE; FEMALE; FOOD DRUG INTERACTION; HUMAN; MALE; NUTRIENT CONTENT; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SUGAR INTAKE; SYMPTOMATOLOGY;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; CLOZAPINE; DIET; DIETARY FATS; DIETARY SUCROSE; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SCHIZOPHRENIA; SMOKING;

EID: 12344324556     PISSN: 1028415X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10284150400010012     Document Type: Article

References (12)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM IV), 4th Ed. (APA, Washington, D.C.).
2. Brown, S., Birtwistle, L.R. and Thompson, C. (1999) "The unhealthy lifestyle of people with schizophrenia", Psychological Medicine 29, 697-701.
3. Brown, S., Inskip, H. and Barraclough, B. (2002) "Causes of the excess mortality of schizophrenia", British Journal of Psychiatry 177, 212-217.
4. Christensen, O. and Christensen, E. (1988) "Fat consumption and schizophrenia", Acta Psychiatrica Scandinavica 78, 587-591.
5. Gregory, J., Foster, K., Tyler, H. and Wiseman, M. (1990) The Dietary and Nutritional Survey of British Adults (HMSO, London).
6. Mc Creadie, R., MacDonald, E., Blacklock, C., et al. (1998) "Dietary intake of schizophrenic patients in Nithsdale, Scotland: a case-control study", British Medical Journal 317, 784-785.
7. Mellor, J.E., Laugharne, J.D.E. and Peet, M. (1996) "Omega-3 fatty acid supplementation in schizophrenic patients", Human Psychopharmacology. 11, 39-46.
8. Meltzer, H.Y., Perry E. and Jayathilake, K. (2003) "Clozapine-induced weight gain predicts improvement in psychopathology", Schizophrenia Research 59(1), 19-27.
9. Overall, J.E. and Gorham, D.R. (1962) "The brief psychiatric rating scale", Psychology Reports 10, 799-812.
10. Peet, M. (2002) "Essential fatty acids: Theoretical aspects and treatment implications for schizophrenia and depression", Advances in Psychiatric Treatment 8, 223-229.
11. Peet, M. (2004) "International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis", British Journal of Psychiatry 184, 404-408.
12. Sernyak, M.J., Leslie, D.L., Alarcon, R.D., et al. (2002) "Associates of diabetes mellitus with use of a typical neuroleptics in the treatment of schizophrenia", American Journal of Psychiatry 159, 561-566.